Keyword: Insys Therapeutics
In its latest crackdown on the opioid epidemic, the Department of Justice took a first-of-its-kind legal action against two Ohio doctors.
A new ProPublica analysis shows that drugmakers spent less money to market opioids to doctors in 2016 than in prior years.
A Florida doctor pleaded guilty to taking kickbacks and agreed to a $2.8 million settlement and more physician practice news.
Physicians say they face long wait times for insurers to process prior authorizations and more physician practice news.
The opioid epidemic has cost more than $1 trillion since 2001—an amount that will likely grow over the next several years.
Increasingly, companies that manufacture opioids and the physicians who prescribe them are facing serious criminal charges.
Federal and state authorities are pursuing pharmaceutical kickback schemes involving sham speaker programs, including one scheme in which doctors were paid thousands of dollars to prescribe a highly addictive fentanyl spray. Two former employees of an Arizona pharmaceutical company were arrested last week for allegedly paying physicians for sham educational programs that that often led to social outings at bars and clubs, according to the United States Attorney’s Office for the Southern District of New York.